Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250925 · ClinicalTrials.gov registry record · Phase 4
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
A Phase 4 study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- Phase 4
- Development phase
- 94
- Enrollment target
NCT01250925 is a Phase 4 study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 94 participants.
The verdict
NCT01250925, a Phase 4 study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to utilize in-vivo confocal microscopy to describe differences in corneal epithelial immune status across three lens care regimens in new contact lens wearers.
Interventions
- DRUG ReNu MultiPlus® MultiPurpose Solution
- DRUG OPTI-FREE® RepleniSH®
- DRUG Clear Care®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01250925
The ClinicalTrials.gov registry entry for NCT01250925 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ReNu MultiPlus® MultiPurpose Solution is the first listed.
NCT01250925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01250925 about?
NCT01250925 is a clinical study titled "Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface". The purpose of this study is to utilize in-vivo confocal microscopy to describe differences in corneal epithelial immune status across three lens care regimens in new contact lens wearers.
What is the current status of trial NCT01250925?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2010-08. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01250925?
The interventions under investigation include: ReNu MultiPlus® MultiPurpose Solution (DRUG), OPTI-FREE® RepleniSH® (DRUG), Clear Care® (DRUG).
Who is sponsoring clinical trial NCT01250925?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.